ON DEMAND Webinar: Spotlight on emerging therapies for patients with EGFR-positive NSCLC
2 April 2021 - 90 Minutes

ON DEMAND Webinar: Spotlight on emerging therapies for patients with EGFR-positive NSCLC

Learning objective:         

After watching this webinar, participants should be able to:

  • Describe the novel paradigms for TKI resistant disease in advanced NSCLC patients with common EGFR mutations
  • Evaluate the unmet needs for advanced NSCLC patients with EGFR exon 20 insertions
  • Identify and review the latest advances of the emerging options in ...
more info...

EM-53390
Experts’ views on bladder cancer news from February 2021
17 February 2021 - 59 Minutes

Experts’ views on bladder cancer news from February 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss new data in bladder cancer
  • Integrate new data into the current disease landscape

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)
  • Petros Grivas (USA)
  • Shahrokh Shariat (Austria)
more info...

EM-50845
Experts’ views on prostate cancer news from February 2021
15 February 2021 - 61 Minutes

Experts’ views on prostate cancer news from February 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the recent data on prostate cancer from February
  • Discuss how these recent data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kim Chi (Canada)
  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Fred Saad (Canada)
more info...

EM-50843
ON DEMAND webinar: What the future holds for advanced NSCLC patients with resistance to EGFR TKIs
15 February 2021 - 58 Minutes

ON DEMAND webinar: What the future holds for advanced NSCLC patients with resistance to EGFR TKIs

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss the unmet needs for advanced NSCLC patients with EGFR Exon20 insertion mutations
  • Discuss the latest data on novel treatments in this patient group
  • Understand the novel management paradigms for TKI resistant disease in advanced NSCLC patients with EGFR mutations

 

Faculty:

  • Tetsuya ...

more info...

EM-52440
An expert review of the NSCLC landscape: EGFR in focus
5 February 2021 - 62 Minutes

An expert review of the NSCLC landscape: EGFR in focus

Learning objectives:

After watching this broadcast, participants should be able to:

  • Evaluate the emerging treatment options available for EGFR-positive NSCLC
  • Describe how ongoing research into EGFR exon 20 insertions might drive clinical decision-making in patients with intrinsic resistance to EGFR TKIs

 

Co-chairs:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

Faculty:

  • Joshua Bauml (USA)
  • Luis Paz-Ares (Spain)

 

more info...

EM-51285
A review of bladder cancer in 2020
3 December 2020 - 59 Minutes

A review of bladder cancer in 2020

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Analyse the new developments in the field of advanced urothelial cancer
  • Reflect upon the implications for the disease landscape

 

Scientific Committee:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)

 

Faculty:

  • Alvaro Pinto (Spain)
  • Antonio López-Beltrán (Portugal)
  • James Catto (UK)
more info...

EM-45563
A review of prostate cancer in 2020
1 December 2020 - 60 Minutes

A review of prostate cancer in 2020

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer in 2020
  • Discuss how these new data will affect daily clinical practice

 

Scientific Committee:

  • Kurt Miller (Germany)
  • Heather Payne (UK)

 

Faculty:

  • Noel Clarke (UK)
  • Laura-Maria Krabbe (Germany)
  • Alvaro Pinto (Spain)
more info...

EM-45556
The future is now: The role of precision medicine in advanced prostate cancer and bladder cancer
13 November 2020 - 51 Minutes

The future is now: The role of precision medicine in advanced prostate cancer and bladder cancer

Learning objective:         

After participating in this symposium, attendees should be able to:

  • Describe the potential benefits of precision medicine, considering the complexity and diversity in disease states of patients with advanced prostate cancer and bladder cancer
  • Discuss the current state of precision medicine and the treatment modalities available for patients with advanced ...
more info...

EM-45815
Plenary session Digital GU Debates
20 October 2020 - 51 Minutes

Plenary session Digital GU Debates

The meeting will be focused on current challenges and recent advances in the management of GU cancers and on how we can improve the lives of those we treat by focusing on aspects such as the psychological and physical impact of treatments or on the patient support network. Moreover, if you register for this event, you will receive a confirmation ...

more info...

EM-30025
Breakout 1: The impact of PC treatment: bone health and the management of pain and fatigue
20 October 2020 - 29 Minutes

Breakout 1: The impact of PC treatment: bone health and the management of pain and fatigue

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe strategies for managing pain, fatigue and bone health in patients with PC and reflect on how these strategies can be integrated into clinical practice

 

Faculty:

  • Daniele Santini (Italy)
  • Joe O’Sullivan (UK)
more info...

EM-45810
;